The maker of an at-home cervical cancer screening test said Friday it has won approval from the Food and Drug Administration, giving patients an alternative to in-clinic pap smears.

Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. Click here to find out why NVAX ...

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Meanwhile, Axios reports the FDA is making plans to use AI in its decision-making. Also: President Donald Trump is set to sign an executive order to bring down the cost of meds.

Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

Less than half of Americans have confidence in federal public health agencies’ ability to regulate prescriptions, approve ...